414 related articles for article (PubMed ID: 11380830)
41. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
42. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
[TBL] [Abstract][Full Text] [Related]
43. A Protein Extract from Chicken Reduces Plasma Homocysteine in Rats.
Lysne V; Bjørndal B; Vik R; Nordrehaug JE; Skorve J; Nygård O; Berge RK
Nutrients; 2015 Jun; 7(6):4498-511. PubMed ID: 26053618
[TBL] [Abstract][Full Text] [Related]
44. Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
Lever M; George PM; Dellow WJ; Scott RS; Chambers ST
Metabolism; 2005 Jan; 54(1):1-14. PubMed ID: 15562374
[TBL] [Abstract][Full Text] [Related]
45. Plasma homocysteine concentration changes after renal transplantation in children.
Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
[TBL] [Abstract][Full Text] [Related]
46. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
47. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
[TBL] [Abstract][Full Text] [Related]
48. Vitamin B12 and folate deficiency and elevated plasma total homocysteine in workers with chronic exposure to chromate.
Wang TC; Jia G; Zhang J; Ma YH; Liu LZ; Zhang N; Feng WY; Zhou JW; Song YS; Yan L; Du XM
Occup Environ Med; 2011 Dec; 68(12):870-5. PubMed ID: 21508429
[TBL] [Abstract][Full Text] [Related]
49. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
Gopinath B; Flood VM; Rochtchina E; Thiagalingam A; Mitchell P
Eur J Prev Cardiol; 2012 Dec; 19(6):1420-9. PubMed ID: 21960652
[TBL] [Abstract][Full Text] [Related]
50. Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism.
Ozmen B; Ozmen D; Parildar Z; Mutaf I; Turgan N; Bayindir O
Endocr J; 2006 Feb; 53(1):119-24. PubMed ID: 16543681
[TBL] [Abstract][Full Text] [Related]
51. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
52. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
53. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
Leskinen Y; Lehtimäki T; Loimaala A; Huhtala H; Salenius JP; Oja SS; Saha H
Atherosclerosis; 2004 Aug; 175(2):315-23. PubMed ID: 15262188
[TBL] [Abstract][Full Text] [Related]
54. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
55. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
56. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy.
van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Perit Dial Int; 1998; 18(3):282-9. PubMed ID: 9663892
[TBL] [Abstract][Full Text] [Related]
57. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
Obeid R; Kuhlmann MK; Köhler H; Herrmann W
Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294
[TBL] [Abstract][Full Text] [Related]
58. Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C->t genotypes and B-vitamin status in a large-scale epidemiological study.
Holm PI; Hustad S; Ueland PM; Vollset SE; Grotmol T; Schneede J
J Clin Endocrinol Metab; 2007 Apr; 92(4):1535-41. PubMed ID: 17284634
[TBL] [Abstract][Full Text] [Related]
59. Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD).
Slow S; Vasudevamurthy M; Fraser R; McEntyre C; Lever M; Chambers S; George P
Exp Toxicol Pathol; 2007 Apr; 58(5):285-90. PubMed ID: 17175148
[TBL] [Abstract][Full Text] [Related]
60. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
